Role of peroxisome proliferator-activated receptor γ in amyloid precursor protein processing and amyloid β-mediated cell death

被引:73
作者
d'Abramo, C
Massone, S
Zingg, JM
Pizzuti, A
Marambaud, P
Dalla Piccola, B
Azzi, A
Marinari, UM
Pronzato, MA
Ricciarelli, R [1 ]
机构
[1] Univ Genoa, Dept Expt Med, I-16132 Genoa, Italy
[2] Univ Bern, Inst Biochem & Mol Biol, CH-3012 Bern, Switzerland
[3] Univ Roma La Sapienza, Inst Med, I-00198 Rome, Italy
[4] IRCCS, Casa Sollievo Sofferenza, I-00198 Rome, Italy
[5] N Shore LIJ Res Inst, New York, NY 11030 USA
关键词
Alzheimer's disease; non-steroidal anti-inflammatory drugs (NSAIDs); peroxisome proliferator-activated receptor gamma (PPAR gamma); amyloid-beta; amyloid precursor protein (APP);
D O I
10.1042/BJ20050560
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent data indicate that PPAR gamma (peroxisome proliferator-activated receptor gamma) could be involved in the modulation of the amyloid cascade causing Alzheimer's disease. In the present study we show that PPAR gamma overexpression in cultured cells dramatically reduced A beta (amyloid-beta) secretion, affecting the expression of the APP (A beta precursor protein) at a post-transcriptional level. APP down-regulation did not involve the pathway of the secretases, and correlated with a significant induction of APP ubiquitination. Additionally, we demonstrate that PPAR gamma was able to protect the cells from H2O2-induced necrosis by decreasing A beta secretion. Taken together, our results indicate a novel mechanism at the basis of the neuroprotection shown by PPAR gamma agonists and an additional pathogenic role for A beta accumulation.
引用
收藏
页码:693 / 698
页数:6
相关论文
共 27 条
[11]   Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease [J].
Lim, GP ;
Yang, F ;
Chu, T ;
Chen, P ;
Beech, W ;
Teter, B ;
Tran, T ;
Ubeda, O ;
Ashe, KH ;
Frautschy, SA ;
Cole, GM .
JOURNAL OF NEUROSCIENCE, 2000, 20 (15) :5709-5714
[12]   THE NUCLEAR RECEPTOR SUPERFAMILY - THE 2ND DECADE [J].
MANGELSDORF, DJ ;
THUMMEL, C ;
BEATO, M ;
HERRLICH, P ;
SCHUTZ, G ;
UMESONO, K ;
BLUMBERG, B ;
KASTNER, P ;
MARK, M ;
CHAMBON, P ;
EVANS, RM .
CELL, 1995, 83 (06) :835-839
[13]   Constitutive and protein kinase C-regulated secretory cleavage of Alzheimer's beta-amyloid precursor protein: Different control of early and late events by the proteasome [J].
Marambaud, P ;
LopezPerez, E ;
Wilk, S ;
Checler, F .
JOURNAL OF NEUROCHEMISTRY, 1997, 69 (06) :2500-2505
[14]   Peroxisome proliferator-activated receptors and atherogenesis - Regulators of gene expression in vascular cells [J].
Marx, N ;
Duez, H ;
Fruchart, JC ;
Staels, B .
CIRCULATION RESEARCH, 2004, 94 (09) :1168-1178
[15]   Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease β-amyloid protein precursor:: Effect of C-terminal truncation on production of β-amyloid protein [J].
Nunan, J ;
Williamson, NA ;
Hill, AF ;
Sernee, MF ;
Masters, CL ;
Small, DH .
JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 74 (03) :378-385
[16]   Nuclear receptors in Sicily: All in the famiglia [J].
Perlmann, T ;
Evans, RM .
CELL, 1997, 90 (03) :391-397
[17]  
Qin CH, 2003, CANCER RES, V63, P958
[18]   Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells [J].
Ricciarelli, R ;
Zingg, JM ;
Azzi, A .
CIRCULATION, 2000, 102 (01) :82-87
[19]   Assessment of proteasome activity in cell lysates and tissue homogenates using peptide substrates [J].
Rodgers, KJ ;
Dean, RT .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2003, 35 (05) :716-727
[20]   CLINICAL-TRIAL OF INDOMETHACIN IN ALZHEIMERS-DISEASE [J].
ROGERS, J ;
KIRBY, LC ;
HEMPELMAN, SR ;
BERRY, DL ;
MCGEER, PL ;
KASZNIAK, AW ;
ZALINSKI, J ;
COFIELD, M ;
MANSUKHANI, L ;
WILLSON, P ;
KOGAN, F .
NEUROLOGY, 1993, 43 (08) :1609-1611